|
Feature
|
Valid N
|
Trials with feature that recruited successfully* n (%)
|
Trials that didn't have feature that recruited successfully* n (%)
|
Odds Ratio
|
95%CI
|
p-value
|
|---|
|
Local recruitment coordinators
|
100
|
15/69 (22)
|
14/31 (45)
|
0.34
|
0.14, 0.84
|
0.017
|
|
Simple design
|
122
|
35/116 (30)
|
3/6 (50)
|
0.43
|
0.06, 3.41
|
0.374
|
|
Support from a trials unit
|
122
|
27/94 (29)
|
11/28 (39)
|
0.62
|
0.26, 1.50
|
0.289
|
|
Multidisciplinary input
|
113
|
34/104 (33)
|
3/9 (33)
|
0.97
|
0.19, 6.36
|
0.615
|
|
Pilot phase
|
109
|
18/66 (27)
|
11/43 (26)
|
1.09
|
0.46, 2.61
|
0.845
|
|
Good level of funding
|
89
|
7/24 (29)
|
17/65 (26)
|
1.16
|
0.41, 3.29
|
0.776
|
|
Drug trial
|
122
|
19/53 (36)
|
19/69 (28)
|
1.47
|
0.68, 3.18
|
0.326
|
|
Interventions only available inside the trial
|
112
|
7/18 (39)
|
26/94 (28)
|
1.66
|
0.58, 4.76
|
0.338
|
|
Consumer input
|
107
|
4/9 (44)
|
26/91 (29)
|
2.00
|
0.36, 10.05
|
0.446
|
|
Funded by the MRC
|
122
|
28/74 (38)
|
10/48 (21)
|
2.31
|
1.00, 5.36
|
0.048
|
|
Cancer trial
|
122
|
12/24 (50)
|
26/98 (27)
|
2.77
|
1.11, 6.93
|
0.026
|
|
Dedicated trial manager
|
107
|
32/91 (35)
|
2/16 (13)
|
3.80
|
0.79, 36.14
|
0.087
|
- * ≥ 100% of original target
